Novel cytokine-independent induction of endothelial adhesion molecules regulated by plateletl/endothelial cell adhesion molecule (CD31)

被引:50
作者
Litwin, M
Clark, K
Noack, L
Furze, J
Berndt, M
Albelda, S
Vadas, M
Gamble, J
机构
[1] INST MED & VET SCI, DIV HUMAN IMMUNOL, HANSON CTR CANC RES, ADELAIDE, SA 5000, AUSTRALIA
[2] BAKER MED RES INST, VASC BIOL LAB, PRAHRAN, VIC 3181, AUSTRALIA
[3] UNIV PENN, MED CTR, DEPT MED, DIV PULM & CRIT CARE, PHILADELPHIA, PA 19104 USA
关键词
D O I
10.1083/jcb.139.1.219
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tumor necrosis factor-alpha, interleukin-1, and endotoxin stimulate the expression of vascular endothelial cell (EC) adhesion molecules. Here we describe a novel pathway of adhesion molecule induction that is independent of exogenous factors, but which is dependent on integrin signaling and cell-cell interactions. Cells plated onto gelatin, fibronectin, collagen or fibrinogen, or anti-integrin antibodies, expressed increased amounts of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1. In contrast, ECs failed to express E-selectin when plated on poly-L-lysine or when plated on fibrinogen in the presence of attach ment-inhibiting, cyclic Arg-Gly-Asp peptides. The duration and magnitude of adhesion molecule expression was dependent on EC density. Induction of E-selectin on ECs plated at confluent density was transient and returned to basal levels by 15 h after plating when only 7 +/- 2% (n = 5) of cells were positive. In contrast, cells plated at low density displayed a 17-fold greater expression of E-selectin than did high density ECs with 57 +/- 4% (n = 5) positive for E-selectin expression 15 h after plating, and significant expression still evident 72 h after plating. The confluency-dependent inhibition of expression of E-selectin was at least partly mediated through the cell junctional protein, platelet/endothelial cell adhesion molecule-1 (PECAM-1). Antibodies against PECAM-1, but not against VE-cadherin, increased E-selectin expression on confluent ECs. Coculture of subconfluent ECs with PECAM-1-coated beads or with L cells transfected with full-length PECAM-1 or with a cytoplasmic truncation PECAM-1 mutant, inhibited-E-selectin expression. In contrast, untransfected L cells or L cells transfected with an adhesion-defective domain 2 deletion PECAM-1 mutant failed to regulate E-selectin expression. In an in vitro model of wounding the wound front displayed an increase in the number of E-selectin-expressing cells, and also an increase in the intensity of expression of E-selectin positive cells compared to the nonwounded monolayer. Thus we propose that the EC junction, and in particular, the junctional molecule PECAM-1, is a powerful regulator of endothelial adhesiveness.
引用
收藏
页码:219 / 228
页数:10
相关论文
共 54 条
[11]  
CHEN SC, 1995, CELL GROWTH DIFFER, V6, P681
[12]   MOLECULAR AND FUNCTIONAL-ASPECTS OF PECAM-1 CD31 [J].
DELISSER, HM ;
NEWMAN, PJ ;
ALBELDA, SM .
IMMUNOLOGY TODAY, 1994, 15 (10) :490-495
[13]  
DELISSER HM, 1993, J BIOL CHEM, V268, P16037
[14]  
DOHERTY DE, 1989, J IMMUNOL, V143, P3673
[15]   MAPPING THE HOMOTYPIC BINDING-SITES IN CD31 AND THE ROLE OF CD31 ADHESION IN THE FORMATION OF INTERENDOTHELIAL CELL CONTACTS [J].
FAWCETT, J ;
BUCKLEY, C ;
HOLNESS, CL ;
BIRD, IN ;
SPRAGG, JH ;
SAUNDERS, J ;
HARRIS, A ;
SIMMONS, DL .
JOURNAL OF CELL BIOLOGY, 1995, 128 (06) :1229-1241
[16]   MORPHOMETRIC ANALYSIS OF BLOOD-VESSELS IN SYNOVIAL MEMBRANES OBTAINED FROM CLINICALLY AFFECTED AND UNAFFECTED KNEE JOINTS OF PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
FITZGERALD, O ;
SODEN, M ;
YANNI, G ;
ROBINSON, R ;
BRESNIHAN, B .
ANNALS OF THE RHEUMATIC DISEASES, 1991, 50 (11) :792-796
[17]   CHANGES IN VASCULAR ENDOTHELIUM RELATED TO LYMPHOCYTE COLLECTIONS IN DISEASED SYNOVIA [J].
FREEMONT, AJ ;
JONES, CJP ;
BROMLEY, M ;
ANDREWS, P .
ARTHRITIS AND RHEUMATISM, 1983, 26 (12) :1427-1433
[18]  
FURIE MB, 1989, J IMMUNOL, V143, P3309
[19]   REGULATION OF INTRACELLULAR PH BY CELL-CELL ADHESIVE INTERACTIONS [J].
GALKINA, SI ;
SUDINA, GF ;
DERGACHEVA, GB ;
MARGOLIS, LB .
FEBS LETTERS, 1995, 374 (01) :17-20
[20]  
GAMBLE JR, 1993, J IMMUNOL, V150, P4494